Literature DB >> 6310039

Mechanism of protection during the early phase of a generalized viral infection. I. Contribution of phagocytes to protection against ectromelia virus.

S Tsuru, H Kitani, M Seno, M Abe, Y Zinnaka, K Nomoto.   

Abstract

Effects of carrageenan and gamma-irradiation on virus titre in the liver were observed after intravenous inoculation of 8 X 10(3) p.f.u. of ectromelia virus which was not lethal for untreated mice. Trapping of virus by the liver within 30 min and an initial transient reduction in titre by day 1 were not affected by gamma-irradiation but were inhibited by pretreatment with carrageenan. An increase from day 1 to day 3 was not affected by gamma-irradiation but was augmented by pretreatment with carrageenan. Therefore, protection within 3 days may depend principally upon carrageenan-sensitive and irradiation-resistant cells, namely, fixed macrophages. Elimination of virus from day 4 to day 7 depended upon cell-mediated immunity. When carrageenan was given 3 days after virus inoculation, the titre of virus increased progressively from day 4 ultimately to kill the hosts. The cytotoxic activity of spleen cells against infected target cells was raised in carrageenan-treated mice as well as in untreated mice. Immune elimination of virus may be mediated by a mechanism requiring the cooperation of sensitized T lymphocytes and blood monocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6310039     DOI: 10.1099/0022-1317-64-9-2021

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

Authors:  R J Jackson; A J Ramsay; C D Christensen; S Beaton; D F Hall; I A Ramshaw
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Depression of protective mechanism during the early phase of a viral infection in tumor-bearing mice and prevention by PSK.

Authors:  S Tsuru; K Nomoto; M Taniguchi; H Fujisawa; Y Zinnaka
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Immunopathological study of spleen during Japanese encephalitis virus infection in mice.

Authors:  A Mathur; M Bharadwaj; R Kulshreshtha; S Rawat; A Jain; U C Chaturvedi
Journal:  Br J Exp Pathol       Date:  1988-06

4.  Different roles for CD4+ and CD8+ T lymphocytes and macrophage subsets in the control of a generalized virus infection.

Authors:  G Karupiah; R M Buller; N Van Rooijen; C J Duarte; J Chen
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection.

Authors:  Lauren W Kaminsky; Janet J Sei; Nikhil J Parekh; Michael L Davies; Irene E Reider; Tracy E Krouse; Christopher C Norbury
Journal:  J Virol       Date:  2015-07-22       Impact factor: 5.103

6.  Importance of interferons in recovery from mousepox.

Authors:  G Karupiah; T N Fredrickson; K L Holmes; L H Khairallah; R M Buller
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

Review 7.  Poxvirus pathogenesis.

Authors:  R M Buller; G J Palumbo
Journal:  Microbiol Rev       Date:  1991-03

8.  Differential pathogenesis of lethal mousepox in congenic DBA/2 mice implicates natural killer cell receptor NKR-P1 in necrotizing hepatitis and the fifth component of complement in recruitment of circulating leukocytes to spleen.

Authors:  D G Brownstein; L Gras
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

9.  Primary human macrophages serve as vehicles for vaccinia virus replication and dissemination.

Authors:  Daniel Byrd; Nicole Shepherd; Jie Lan; Ningjie Hu; Tohti Amet; Kai Yang; Mona Desai; Qigui Yu
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

10.  Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and trafficking.

Authors:  Min Fang; Felicia Roscoe; Luis J Sigal
Journal:  J Exp Med       Date:  2010-09-27       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.